{"id":"NCT01718509","sponsor":"Shire","briefTitle":"SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder","officialTitle":"The SPD489-344, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11-26","primaryCompletion":"2013-09-20","completion":"2013-09-20","firstPosted":"2012-10-31","resultsPosted":"2014-08-21","lastUpdate":"2021-07-16"},"enrollment":390,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Binge Eating Disorder"],"interventions":[{"type":"DRUG","name":"SPD489 (Lisdexamfetamine dimesylate)","otherNames":["Vyvanse, Venvanse, LDX"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"SPD489 (Lisdexamfetamine dimesylate)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of the study is to demonstrate the efficacy of SPD489 compared with placebo in adults (18 55 years of age inclusive) with moderate to severe Binge Eating Disorder at Visit 8 (Weeks 11 and 12) as measured by the number of binge days (defined as days during which at least 1 binge episode occurs) per week as assessed by clinical interview based on subject diary","primaryOutcome":{"measure":"Change From Baseline in the Number of Binge Days Per Week at Visit 8 Which Spans Weeks 11/12","timeFrame":"Baseline and Visit 8 Which Spans Weeks 11/12","effectByArm":[{"arm":"PLACEBO","deltaMin":-2.26,"sd":0.137},{"arm":"SPD489","deltaMin":-3.92,"sd":0.135}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":48,"countries":["United States","Germany"]},"refs":{"pmids":["26346638","32237290","30817099","30013816","29497297"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":185},"commonTop":["Dry mouth","Headache","Fatigue","Insomnia","Nausea"]}}